International Journal of Trichology International Journal of Trichology
 Print this page Email this page Small font sizeDefault font sizeIncrease font size
 
 
  Home | About IJT | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submission | Subscribe | Advertise | Contact us | Login   
 
CASE REPORT
Year : 2019  |  Volume : 11  |  Issue : 6  |  Page : 241-243

Therapy-recalcitrant folliculitis decalvans controlled successfully with adalimumab


1 Department of Dermatology, Faculty of Medicine, Al Rass General Hospital, Ministry of Health, Ar Rass, Saudi Arabia
2 Department of Dermatology, Head of Hair Disorder Unit, King Fahed Armed Forced Hospital, Jeddah, Saudi Arabia

Correspondence Address:
Dr. Adel M Alsantali
Department of Dermatology, Head of Hair Disorder Unit, King Fahed Armed Forced Hospital, Jeddah
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijt.ijt_92_19

Rights and Permissions

Folliculitis decalvans (FD) is a rare idiopathic primary cicatricial alopecia which leads to permanent destruction of hair follicular stem cell.Staphylococcus aureus as well as autoimmunity has been implicated in the pathogenesis. Treatment options include topical antiseptics, topical and systemic corticosteroids, systemic antibiotics, isotretinoin, dapsone, hydroxychloroquine, and immunomodulators. We present the therapy-recalcitrant case of FD which is controlled successfully by subcutaneous injections of Adalimumab (Humira®) with no serious adverse events throughout the treatment.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1727    
    Printed24    
    Emailed0    
    PDF Downloaded20    
    Comments [Add]    

Recommend this journal